North America:

  • Intel warns that U.S. government stakes could hinder international sales and future grants, despite an $8.9 billion investment.
  • Royalty Pharma acquires royalty interests in Amgen's lung cancer drug for up to $950 million.
  • Crescent Energy acquires Vital Energy in a $3.1 billion all-stock deal.
  • Thoma Bravo is nearing a deal to acquire Verint Systems for approximately $2 billion.
  • Keurig Dr Pepper has acquired Dutch coffee company JDE Peet's in a deal valued at approximately $18.4 billion.
  • PDD Holdings surpasses quarterly revenue estimates due to domestic demand rebound and international growth.

Europe:

  • UniCredit increases its stake in Commerzbank to 26% by converting derivatives into shares, despite German government opposition.
  • Orsted faces a setback as its US wind project, Revolution Wind, is halted, affecting capital-raising plans.
  • Equinor makes multiple oil and gas discoveries near Norway's Troll field and starts operations at the Northern Lights CCS project.
  • Sweden through Saab, signs a contract to sell four Gripen E/F fighter jets to Thailand for 5.3 billion Swedish kronor.

Rest of the world:

  • Santos extends exclusivity for an $18.7 billion offer led by ADNOC and reports a significant drop in half-year profit.
  • Sasol reports an annual profit due to higher chemical prices, despite a challenging environment and no final dividend.
  • Mercedes-Benz Pension Trust plans to sell its $346 million stake in Nissan Motor.
  • IndusInd Bank appoints Rajiv Anand as CEO and addresses a $230 million loss due to misaccounted trades.